When people ask me what I do at CIRM I sometimes half-jokingly tell them that I’m the official translator: I take complex science and turn it into everyday English. That’s important. The taxpayers of California have a right to know how their money is being spent and how it might benefit them. But that message … Continue reading Explaining COVID can be a pitch
Dr. Helen Blau
Stem Cell Agency Board Approves Three More Projects Targeting COVID-19
Dr. Jianhua Yu (left), Dr. Helen Blau (center), and Dr. Albert Wong (right) The COVID-19 virus targets many different parts of the body, often with deadly or life-threatening consequences. This past Friday the governing Board of the California Institute for Regenerative Medicine (CIRM) approved investments in three early-stage research programs taking different approaches to battling … Continue reading Stem Cell Agency Board Approves Three More Projects Targeting COVID-19
Spotlight on Muscular Dystrophy and Stem Cell Research
In our latest video, “Spotlight on Muscular Dystrophy and Stem Cell Research” CIRM grantee and Stanford scientist Helen Blau illustrates new methods of modeling to more accurately map how a therapy might work in humans. Dr. Blau studies Duchenne muscular dystrophy (DMD), the most severe form of muscular dystrophy that affects 1 in 3500 boys … Continue reading Spotlight on Muscular Dystrophy and Stem Cell Research